Start free trial

Latest Herantis Pharma News & Updates

See the latest news and media coverage for Herantis Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Herantis Pharma

Clinical-stage neurodegenerative disease drug developer

herantis.com
Headquarters
Espoo, Finland
Founded year
2008
Company type
Public company
Number of employees
23–50
Industry
Pharmaceuticals

Last updated

Latest news about Herantis Pharma

In short: Herantis Pharma reported HER-096 biomarker data, finalized Phase 2 design and secured €12.2 million.

Company announcements

Herantis Pharma

Herantis Pharma finalizes Phase 2a study design

FDA raised no CMC or preclinical concerns; the randomized placebo-controlled study will enroll ~100 early-stage Parkinson's patients in Europe, use the Digital Motor Score, has CRO and >50% funding.

Herantis Pharma

Herantis Pharma releases 2025 Annual Report

Report summarizes clinical progress, including completed Phase 1 for HER-096 with encouraging data, advancing to Phase 2 in Parkinson’s.

Unlock all announcements with a

Media coverage

Kauppalehti

Positive feedback from FDA for Herantis' study

Herantis Pharma prepares study of drug candidate developed for Parkinson's disease. Candidate. Herantis Pharma develops drug for Parkinson's disease. PICTURE: ARTTU LAITALA Today12:29 Updated...

Finanznachrichten

Herantis Pharma Oyj: Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel

EEST Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel The Board of...

Unlock all articles with a

Never miss news about Herantis Pharma

Track Herantis Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Herantis Pharma competitors & trending companies

Browse news for competitors to Herantis Pharma and other trending companies.